is an Organization.
Open Targets is a public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritization. The consortium includes EMBL-EBI, Wellcome Sanger Institute, and major pharmaceutical companies (Genentech, GSK, MSD, Pfizer, Sanofi). Open Targets provides the Open Targets Platform and Open Targets Genetics for exploring drug target-disease associations.
| ID | Category | Number of Products | Description |
|---|---|---|---|
| opentargets | KnowledgeGraph | 7 | Open Targets is a collaborative effort to systematically identify and priorit... |
Created: December 07, 2025 | Last modified: December 07, 2025